The Potential Demand for an HIV/AIDS Vaccine in Brazil
This study assesses the potential demand by the public sector for a preventive HIV/AIDS vaccine in Brazil and the costs of alternative strategies for a vaccination program. Brazil has a mature AIDS epidemic: the percent of the population living wit...
| Main Authors: | , , , , , |
|---|---|
| Format: | Policy Research Working Paper |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2014
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2002/12/2113666/potential-demand-hivaids-vaccine-brazil http://hdl.handle.net/10986/19193 |
| id |
okr-10986-19193 |
|---|---|
| recordtype |
oai_dc |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English en_US |
| topic |
ACQUIRED IMMUNE DEFICIENCY SYNDROME ADHERENCE TO TREATMENT ADULT POPULATION AGED AIDS DEATHS AIDS DISEASE AIDS EPIDEMIC AIDS INCIDENCE AIDS MORBIDITY AIDS MORTALITY AIDS PANDEMIC AIDS PREVENTION AIDS TREATMENT AIDS VACCINE AIDS VACCINE R&D ANTIRETROVIRAL THERAPIES AVERAGE AGE BEHAVIORAL RISK BLOOD SCREENING CANCER CITIES CLINICAL AIDS CONDOM DISTRIBUTION CONDOM USE CRACK CURRENCY DEATH RATE DENTAL SERVICES DIARRHEA DISTRIBUTION OF CONDOMS DRUGS DRUGS USERS ECONOMICS EFFECTIVE VACCINES EPIDEMIOLOGICAL SURVEILLANCE EPIDEMIOLOGY EXPENDITURES FAMILIES FEMALE CONDOMS FIRST SEXUAL INTERCOURSE GDP PER CAPITA HEALTH CARE HEALTH INFORMATION HEALTH INFORMATION SYSTEMS HEALTH INSURANCE HEALTH INSURANCE COVERAGE HEALTH INTERVENTIONS HEALTH POLICY HEALTH PROMOTION HEALTH SECTOR HEALTH SERVICES HETEROSEXUAL TRANSMISSION HETEROSEXUALS HIV HIV INFECTION HIV POSITIVE HOME CARE HOSPITALIZATION HOSPITALS HUMAN IMMUNODEFICIENCY VIRUS IMMUNE DEFICIENCY IMMUNITY IMMUNIZATION IMMUNIZATION COVERAGE IMMUNODEFICIENCY INCOME INCOME DISTRIBUTION INFECTIOUS DISEASES INHABITANTS INTERNATIONAL AIDS VACCINE INITIATIVE INTERNATIONAL ORGANIZATIONS INTERVENTION INTRAVENOUS DRUG USERS LIFE EXPECTANCY MALE CONDOMS MARKETING NATIONAL HEALTH NEW AIDS CASES NEW CASES NON-GOVERNMENTAL ORGANIZATIONS NURSING PANDEMIC PATIENTS PHARMACEUTICAL COMPANIES PHYSICIANS POLICY DOCUMENTS POLICY RESEARCH PPP PREGNANCIES PREMATURE DEATH PREVENTIVE MEDICINE PRIVATE HEALTH EXPENDITURES PRIVATE INSURANCE PRIVATE SECTOR PUBLIC HEALTH PUBLIC HEALTH SERVICES PUBLIC SECTOR PUBLIC SERVICES PURCHASING POWER PARITY QUALITY OF LIFE RISK GROUPS RISK REDUCTION RISK REDUCTION INTERVENTIONS SAFETY SEX SEX WITH MEN SEXUAL INTERCOURSE SEXUALLY ACTIVE SEXUALLY TRANSMITTED INFECTIONS THERAPEUTIC INTERVENTIONS THERAPEUTIC MEASURES TOTAL POPULATION TRANSMISSION UNAIDS URBANIZATION VACCINATION VACCINE RESEARCH VACCINE TRIALS |
| spellingShingle |
ACQUIRED IMMUNE DEFICIENCY SYNDROME ADHERENCE TO TREATMENT ADULT POPULATION AGED AIDS DEATHS AIDS DISEASE AIDS EPIDEMIC AIDS INCIDENCE AIDS MORBIDITY AIDS MORTALITY AIDS PANDEMIC AIDS PREVENTION AIDS TREATMENT AIDS VACCINE AIDS VACCINE R&D ANTIRETROVIRAL THERAPIES AVERAGE AGE BEHAVIORAL RISK BLOOD SCREENING CANCER CITIES CLINICAL AIDS CONDOM DISTRIBUTION CONDOM USE CRACK CURRENCY DEATH RATE DENTAL SERVICES DIARRHEA DISTRIBUTION OF CONDOMS DRUGS DRUGS USERS ECONOMICS EFFECTIVE VACCINES EPIDEMIOLOGICAL SURVEILLANCE EPIDEMIOLOGY EXPENDITURES FAMILIES FEMALE CONDOMS FIRST SEXUAL INTERCOURSE GDP PER CAPITA HEALTH CARE HEALTH INFORMATION HEALTH INFORMATION SYSTEMS HEALTH INSURANCE HEALTH INSURANCE COVERAGE HEALTH INTERVENTIONS HEALTH POLICY HEALTH PROMOTION HEALTH SECTOR HEALTH SERVICES HETEROSEXUAL TRANSMISSION HETEROSEXUALS HIV HIV INFECTION HIV POSITIVE HOME CARE HOSPITALIZATION HOSPITALS HUMAN IMMUNODEFICIENCY VIRUS IMMUNE DEFICIENCY IMMUNITY IMMUNIZATION IMMUNIZATION COVERAGE IMMUNODEFICIENCY INCOME INCOME DISTRIBUTION INFECTIOUS DISEASES INHABITANTS INTERNATIONAL AIDS VACCINE INITIATIVE INTERNATIONAL ORGANIZATIONS INTERVENTION INTRAVENOUS DRUG USERS LIFE EXPECTANCY MALE CONDOMS MARKETING NATIONAL HEALTH NEW AIDS CASES NEW CASES NON-GOVERNMENTAL ORGANIZATIONS NURSING PANDEMIC PATIENTS PHARMACEUTICAL COMPANIES PHYSICIANS POLICY DOCUMENTS POLICY RESEARCH PPP PREGNANCIES PREMATURE DEATH PREVENTIVE MEDICINE PRIVATE HEALTH EXPENDITURES PRIVATE INSURANCE PRIVATE SECTOR PUBLIC HEALTH PUBLIC HEALTH SERVICES PUBLIC SECTOR PUBLIC SERVICES PURCHASING POWER PARITY QUALITY OF LIFE RISK GROUPS RISK REDUCTION RISK REDUCTION INTERVENTIONS SAFETY SEX SEX WITH MEN SEXUAL INTERCOURSE SEXUALLY ACTIVE SEXUALLY TRANSMITTED INFECTIONS THERAPEUTIC INTERVENTIONS THERAPEUTIC MEASURES TOTAL POPULATION TRANSMISSION UNAIDS URBANIZATION VACCINATION VACCINE RESEARCH VACCINE TRIALS Dutilh Novaes, Hillegonda Maria Luna, Expedito J.A. Goldbaum, Moises Kilsztajn, Samuel Rossbach, Anaclaudia de la Roca Carvalheiro, Jose The Potential Demand for an HIV/AIDS Vaccine in Brazil |
| geographic_facet |
Latin America & Caribbean Brazil |
| relation |
Policy Research Working Paper;No. 2940 |
| description |
This study assesses the potential demand
by the public sector for a preventive HIV/AIDS vaccine in
Brazil and the costs of alternative strategies for a
vaccination program. Brazil has a mature AIDS epidemic: the
percent of the population living with HIV or AIDS (about 0.6
percent of adults) is not as high as in other severely
affected developing countries, but infection rates in
specific risk groups in the population are very high and HIV
has spread beyond these groups into the general population
of low-risk individuals. Preventive HIV/AIDS vaccines are
still in the testing stage. The characteristics of the first
vaccines developed, in terms of their efficacy, duration of
effectiveness, ease of administration, and price, are still
unknown. But the potential benefits of such a vaccine in
Brazil would be high. The study reviews the cost and impact
of HIV/AIDS in Brazil, in terms of disease and economic
burden, as a proxy for the benefits of an HIV/AIDS vaccine.
The epidemiology of AIDS and Brazil's experience with
immunization coverage with other vaccines are used to assess
the number of vaccines, delivery strategies, and possible
costs of an HIV/AIDS immunization program in Brazil,
assuming the availability of a 100 percent effective AIDS
vaccine that lasts a lifetime under different pricing and
dosing assumptions. A low-cost, highly effective vaccine
would likely be affordable to an upper-middle-income country
like Brazil and yield large benefits from a policy of
universal, publicly subsidized immunization. But if prices
are higher and the impact less favorable, the costs and
effects would have to be compared with other AIDS prevention
programs or other health interventions. Both political and
economic considerations will likely figure into public
policy on HIV/AIDS vaccination, when such a vaccine is developed. |
| format |
Publications & Research :: Policy Research Working Paper |
| author |
Dutilh Novaes, Hillegonda Maria Luna, Expedito J.A. Goldbaum, Moises Kilsztajn, Samuel Rossbach, Anaclaudia de la Roca Carvalheiro, Jose |
| author_facet |
Dutilh Novaes, Hillegonda Maria Luna, Expedito J.A. Goldbaum, Moises Kilsztajn, Samuel Rossbach, Anaclaudia de la Roca Carvalheiro, Jose |
| author_sort |
Dutilh Novaes, Hillegonda Maria |
| title |
The Potential Demand for an HIV/AIDS Vaccine in Brazil |
| title_short |
The Potential Demand for an HIV/AIDS Vaccine in Brazil |
| title_full |
The Potential Demand for an HIV/AIDS Vaccine in Brazil |
| title_fullStr |
The Potential Demand for an HIV/AIDS Vaccine in Brazil |
| title_full_unstemmed |
The Potential Demand for an HIV/AIDS Vaccine in Brazil |
| title_sort |
potential demand for an hiv/aids vaccine in brazil |
| publisher |
World Bank, Washington, DC |
| publishDate |
2014 |
| url |
http://documents.worldbank.org/curated/en/2002/12/2113666/potential-demand-hivaids-vaccine-brazil http://hdl.handle.net/10986/19193 |
| _version_ |
1764439722249158656 |
| spelling |
okr-10986-191932021-04-23T14:03:43Z The Potential Demand for an HIV/AIDS Vaccine in Brazil Dutilh Novaes, Hillegonda Maria Luna, Expedito J.A. Goldbaum, Moises Kilsztajn, Samuel Rossbach, Anaclaudia de la Roca Carvalheiro, Jose ACQUIRED IMMUNE DEFICIENCY SYNDROME ADHERENCE TO TREATMENT ADULT POPULATION AGED AIDS DEATHS AIDS DISEASE AIDS EPIDEMIC AIDS INCIDENCE AIDS MORBIDITY AIDS MORTALITY AIDS PANDEMIC AIDS PREVENTION AIDS TREATMENT AIDS VACCINE AIDS VACCINE R&D ANTIRETROVIRAL THERAPIES AVERAGE AGE BEHAVIORAL RISK BLOOD SCREENING CANCER CITIES CLINICAL AIDS CONDOM DISTRIBUTION CONDOM USE CRACK CURRENCY DEATH RATE DENTAL SERVICES DIARRHEA DISTRIBUTION OF CONDOMS DRUGS DRUGS USERS ECONOMICS EFFECTIVE VACCINES EPIDEMIOLOGICAL SURVEILLANCE EPIDEMIOLOGY EXPENDITURES FAMILIES FEMALE CONDOMS FIRST SEXUAL INTERCOURSE GDP PER CAPITA HEALTH CARE HEALTH INFORMATION HEALTH INFORMATION SYSTEMS HEALTH INSURANCE HEALTH INSURANCE COVERAGE HEALTH INTERVENTIONS HEALTH POLICY HEALTH PROMOTION HEALTH SECTOR HEALTH SERVICES HETEROSEXUAL TRANSMISSION HETEROSEXUALS HIV HIV INFECTION HIV POSITIVE HOME CARE HOSPITALIZATION HOSPITALS HUMAN IMMUNODEFICIENCY VIRUS IMMUNE DEFICIENCY IMMUNITY IMMUNIZATION IMMUNIZATION COVERAGE IMMUNODEFICIENCY INCOME INCOME DISTRIBUTION INFECTIOUS DISEASES INHABITANTS INTERNATIONAL AIDS VACCINE INITIATIVE INTERNATIONAL ORGANIZATIONS INTERVENTION INTRAVENOUS DRUG USERS LIFE EXPECTANCY MALE CONDOMS MARKETING NATIONAL HEALTH NEW AIDS CASES NEW CASES NON-GOVERNMENTAL ORGANIZATIONS NURSING PANDEMIC PATIENTS PHARMACEUTICAL COMPANIES PHYSICIANS POLICY DOCUMENTS POLICY RESEARCH PPP PREGNANCIES PREMATURE DEATH PREVENTIVE MEDICINE PRIVATE HEALTH EXPENDITURES PRIVATE INSURANCE PRIVATE SECTOR PUBLIC HEALTH PUBLIC HEALTH SERVICES PUBLIC SECTOR PUBLIC SERVICES PURCHASING POWER PARITY QUALITY OF LIFE RISK GROUPS RISK REDUCTION RISK REDUCTION INTERVENTIONS SAFETY SEX SEX WITH MEN SEXUAL INTERCOURSE SEXUALLY ACTIVE SEXUALLY TRANSMITTED INFECTIONS THERAPEUTIC INTERVENTIONS THERAPEUTIC MEASURES TOTAL POPULATION TRANSMISSION UNAIDS URBANIZATION VACCINATION VACCINE RESEARCH VACCINE TRIALS This study assesses the potential demand by the public sector for a preventive HIV/AIDS vaccine in Brazil and the costs of alternative strategies for a vaccination program. Brazil has a mature AIDS epidemic: the percent of the population living with HIV or AIDS (about 0.6 percent of adults) is not as high as in other severely affected developing countries, but infection rates in specific risk groups in the population are very high and HIV has spread beyond these groups into the general population of low-risk individuals. Preventive HIV/AIDS vaccines are still in the testing stage. The characteristics of the first vaccines developed, in terms of their efficacy, duration of effectiveness, ease of administration, and price, are still unknown. But the potential benefits of such a vaccine in Brazil would be high. The study reviews the cost and impact of HIV/AIDS in Brazil, in terms of disease and economic burden, as a proxy for the benefits of an HIV/AIDS vaccine. The epidemiology of AIDS and Brazil's experience with immunization coverage with other vaccines are used to assess the number of vaccines, delivery strategies, and possible costs of an HIV/AIDS immunization program in Brazil, assuming the availability of a 100 percent effective AIDS vaccine that lasts a lifetime under different pricing and dosing assumptions. A low-cost, highly effective vaccine would likely be affordable to an upper-middle-income country like Brazil and yield large benefits from a policy of universal, publicly subsidized immunization. But if prices are higher and the impact less favorable, the costs and effects would have to be compared with other AIDS prevention programs or other health interventions. Both political and economic considerations will likely figure into public policy on HIV/AIDS vaccination, when such a vaccine is developed. 2014-08-01T17:16:54Z 2014-08-01T17:16:54Z 2002-12 http://documents.worldbank.org/curated/en/2002/12/2113666/potential-demand-hivaids-vaccine-brazil http://hdl.handle.net/10986/19193 English en_US Policy Research Working Paper;No. 2940 CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank, Washington, DC Publications & Research :: Policy Research Working Paper Publications & Research Latin America & Caribbean Brazil |